Detected ·
Waiv
——
Waiv (formerly Owkin Dx), an AI-powered precision medicine company, closed a $35M funding round with follow-on investment from CRB Health Tech SGEIC. The company has achieved CE marking for two clinical-grade tests and secured a pharma collaboration with Daiichi Sankyo for AI-derived biomarkers.
- Website
- www.wearewaiv.com
- linkedin.com/company/we-are-waiv
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-05-07 12:08:49 UTC
- Signal ID
- 389604b8-7d9f-4593-8e34-1ea729de42ed
As the API returns it
{
"id": "389604b8-7d9f-4593-8e34-1ea729de42ed",
"created_at": "2026-05-07T12:08:49.002703Z",
"company_name": "Waiv",
"company_website_url": "www.wearewaiv.com",
"company_linkedin_url": "https://www.linkedin.com/company/we-are-waiv",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Waiv (formerly Owkin Dx), an AI-powered precision medicine company, closed a $35M funding round with follow-on investment from CRB Health Tech SGEIC. The company has achieved CE marking for two clinical-grade tests and secured a pharma collaboration with Daiichi Sankyo for AI-derived biomarkers.*"
}